Characterization and temporal development of cores in a mouse model of malignant hyperthermia
- PMID: 19966218
- PMCID: PMC2799858
- DOI: 10.1073/pnas.0911496106
Characterization and temporal development of cores in a mouse model of malignant hyperthermia
Abstract
Malignant hyperthermia (MH) and central core disease are related skeletal muscle diseases often linked to mutations in the type 1 ryanodine receptor (RYR1) gene, encoding for the Ca(2+) release channel of the sarcoplasmic reticulum (SR). In humans, the Y522S RYR1 mutation is associated with malignant hyperthermia susceptibility (MHS) and the presence in skeletal muscle fibers of core regions that lack mitochondria. In heterozygous Y522S knock-in mice (RYR1(Y522S/WT)), the mutation causes SR Ca(2+) leak and MHS. Here, we identified mitochondrial-deficient core regions in skeletal muscle fibers from RYR1(Y522S/WT) knock-in mice and characterized the structural and temporal aspects involved in their formation. Mitochondrial swelling/disruption, the initial detectable structural change observed in young-adult RYR1(Y522S/WT) mice (2 months), does not occur randomly but rather is confined to discrete areas termed presumptive cores. This localized mitochondrial damage is followed by local disruption/loss of nearby SR and transverse tubules, resulting in early cores (2-4 months) and small contracture cores characterized by extreme sarcomere shortening and lack of mitochondria. At later stages (1 year), contracture cores are extended, frequent, and accompanied by areas in which contractile elements are also severely compromised (unstructured cores). Based on these observations, we propose a possible series of events leading to core formation in skeletal muscle fibers of RYR1(Y522S/WT) mice: Initial mitochondrial/SR disruption in confined areas causes significant loss of local Ca(2+) sequestration that eventually results in the formation of contractures and progressive degradation of the contractile elements.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Antioxidant Treatment Reduces Formation of Structural Cores and Improves Muscle Function in RYR1Y522S/WT Mice.Oxid Med Cell Longev. 2017;2017:6792694. doi: 10.1155/2017/6792694. Epub 2017 Sep 10. Oxid Med Cell Longev. 2017. PMID: 29062463 Free PMC article.
-
A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4531-6. doi: 10.1073/pnas.0812661106. Epub 2009 Feb 25. Proc Natl Acad Sci U S A. 2009. PMID: 19246389 Free PMC article.
-
Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia.FASEB J. 2017 Aug;31(8):3649-3662. doi: 10.1096/fj.201601292R. Epub 2017 May 2. FASEB J. 2017. PMID: 28465322 Free PMC article.
-
Ryanodine receptor mutations in malignant hyperthermia and central core disease.Hum Mutat. 2000;15(5):410-7. doi: 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 2000. PMID: 10790202 Review.
-
[Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex].Rev Neurol (Paris). 2004 May;160(5 Pt 2):S70-7. doi: 10.1016/s0035-3787(04)71008-5. Rev Neurol (Paris). 2004. PMID: 15269663 Review. French.
Cited by
-
Role of mitochondria-associated endoplasmic reticulum membranes in insulin sensitivity, energy metabolism, and contraction of skeletal muscle.Front Mol Biosci. 2022 Oct 7;9:959844. doi: 10.3389/fmolb.2022.959844. eCollection 2022. Front Mol Biosci. 2022. PMID: 36275635 Free PMC article. Review.
-
Exciting perspectives for Translational Myology in the Abstracts of the 2018Spring PaduaMuscleDays: Giovanni Salviati Memorial - Chapter III - Abstracts of March 16, 2018.Eur J Transl Myol. 2018 Feb 20;28(1):7365. doi: 10.4081/ejtm.2018.7365. eCollection 2018 Jan 12. Eur J Transl Myol. 2018. PMID: 30057727 Free PMC article.
-
Altered Ca2+ Handling and Oxidative Stress Underlie Mitochondrial Damage and Skeletal Muscle Dysfunction in Aging and Disease.Metabolites. 2021 Jun 28;11(7):424. doi: 10.3390/metabo11070424. Metabolites. 2021. PMID: 34203260 Free PMC article. Review.
-
Special article: Future directions in malignant hyperthermia research and patient care.Anesth Analg. 2011 Nov;113(5):1108-19. doi: 10.1213/ANE.0b013e318222af2e. Epub 2011 Jun 27. Anesth Analg. 2011. PMID: 21709147 Free PMC article. Review.
-
Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.PLoS One. 2013;8(1):e54042. doi: 10.1371/journal.pone.0054042. Epub 2013 Jan 7. PLoS One. 2013. PMID: 23308296 Free PMC article.
References
-
- Galli L, et al. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: Evidence for a cluster of novel mutations in the C-terminal region. Cell Calcium. 2002;32:143–151. - PubMed
-
- Monnier N, et al. Presence of two different genetic traits in malignant hyperthermia families: Implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology. 2002;97:1067–1074. - PubMed
-
- MacLennan DH, Phillips MS. Malignant hyperthermia. Science. 1992;256:789–794. - PubMed
-
- Magee KR, Shy GM. A new congenital non-progressive myopathy. Brain. 1956;79:610–621. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous